PHARMAGEN, INC.

Pharmagen, Inc. Stock

Stocks

PHRX

US71715W1062

OTC Markets Traded

Delayed OTC Markets Other stock markets 10:04:13 2026-07-23 EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

15-11-29	Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	CI
14-07-02	Pharmagen, Inc. Announces Management Changes	CI

Valuation: Pharmagen, Inc.

Market Cap	1.14M 1M 929K 855K 1.6M 110M 1.63M 11.11M 4.34M 53.73M 4.27M 4.18M 186M	P/E 2012	-3.8x	P/E 2013	-0.23x
Enterprise Value	5.54M 4.87M 4.53M 4.16M 7.81M 537M 7.95M 54.15M 21.12M 262M 20.81M 20.36M 908M	EV / Sales 2012	3,210,487x	EV / Sales 2013	1,251,231x
Free-Float	-	Yield 2012 *	-	Yield 2013	-

* Estimated data More valuation ratios

Chart: Pharmagen, Inc.

Latest news : Pharmagen, Inc.

15-11-29	Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	CI
14-07-02	Pharmagen, Inc. Announces Management Changes	CI
14-06-11	Pharmagen, Inc. Announces Executive Changes	CI
14-06-11	Pharmagen, Inc. Appoints Russell Skibsted as Executive Vice President and Chief Financial Officer	CI
14-05-29	Pharmagen Appoints Additional Members to its Board of Directors	CI
14-05-06	Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales	CI
14-04-29	Pharmagen, Inc. Appoints Boyd Relac as Chief Operating Officer	CI
14-03-31	Pharmagen, Inc. announced that it has received $0.5 million in funding	CI
14-02-24	Pharmagen, Inc. Appoints Richard A. Wolpow as Member of Board of Directors and Interim-Chief Operating Officer	CI
14-02-24	Pharmagen, Inc. announced that it has received $0.15 million in funding.	CI
13-12-17	Pharmagen, Inc. Appoints Richard A. Wolpow as Chairman of the Board of Directors and Interim Chief Operating Officer	CI
13-12-11	Pharmagen, Inc. announced that it expects to receive $0.5 million in funding	CI
13-11-14	Pharmagen, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013	CI

Press Releases: Pharmagen, Inc.

13-10-09

Pharmagen Inc : Pharmagen Announces Hiring of Quality Control Manager

PR

More press releases

Course Extremes

Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0
10 years	0		0.01

Financials

	2012	2013
Net sales	4.26 3.75 3.48 3.2 6 412.61 6.11 41.63 16.24 201.25 16 15.65 698.2	4.81 4.23 3.93 3.62 6.78 466.1 6.9 47.02 18.34 227.35 18.07 17.68 788.73
Net income	-2.77M -2.44M -2.26M -2.08M -3.91M -268M -3.98M -27.08M -10.56M -131M -10.4M -10.18M -454M	-6M -5.28M -4.9M -4.51M -8.46M -581M -8.61M -58.63M -22.87M -283M -22.53M -22.04M -983M
Net Debt	2.47M 2.17M 2.02M 1.86M 3.48M 239M 3.55M 24.15M 9.42M 117M 9.28M 9.08M 405M	4.4M 3.87M 3.6M 3.31M 6.21M 427M 6.32M 43.04M 16.79M 208M 16.54M 16.18M 722M

* Estimated data More financial data

Company Profile

Employees

24

Sector

-

More about the company

Quotes

Date	Price	Change	Volume
26-07-23	US$0.000001	0.00%	12,100
26-07-15	US$0.000001	0.00%	239,000

Delayed Quote OTC Markets

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
PHRX Stock

The best tools reserved for subscribers to boost the performance of your investments!